Therapeutic nanoreactors:: Combining chemistry and biology in a novel triblock copolymer drug delivery system

被引：177

作者：

Ranquin, A

Versées, W

Meier, W

Steyaert, J

Van Gelder, P

机构：

[1] Vrije Univ Brussels, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium

[2] Vrije Univ Brussels VIB, B-1050 Brussels, Belgium

[3] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland

来源：

NANO LETTERS | 2005年 / 5卷 / 11期

关键词：

D O I：

10.1021/nl051523d

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Triblock copolymeric nanoreactors are introduced as an alternative for liposomes as encapsulating carrier for prodrug activating enzymes. Inosine-adenosine-guanosine preferring nucleoside hydrolase of Trypanosoma vivax, a potential prodrug activating enzyme, was encapsulated in nanometer-sized vesicles constructed of poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-block-(2-methyloxazoline) triblock copolymers. The nanoreactor is functionalized by incorporation of bacterial porins, OmpF or Tsx, in the reactor wall. Efficient cleavage of three natural substrates and one prodrug, 2-fluoroadenosine, by the nanoreactors was demonstrated.

引用

收藏

页码：2220 / 2224

页数：5

相关论文

共 28 条

[1] Dexrazoxane for the prevention of cardiomyopathy in anthracycline treated pediatric cancer patients [J].

Anderson, B .

PEDIATRIC BLOOD & CANCER, 2005, 44 (07) :584-588

[2] MODIFICATION OF ESCHERICHIA-COLI L-ASPARAGINASE WITH POLYETHYLENE-GLYCOL - DISAPPEARANCE OF BINDING ABILITY TO ANTI-ASPARAGINASE SERUM [J].

ASHIHARA, Y ;

KONO, T ;

YAMAZAKI, S ;

INADA, Y .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 83 (02) :385-391

[3] Enzymes and abzymes relationships [J].

Avalle, B ;

Friboulet, A ;

Thomas, D .

JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2000, 10 (1-3) :39-45

[4] A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia [J].

Bauer, KS ;

Karp, JE ;

Garimella, TS ;

Wu, SL ;

Tan, M ;

Ross, DD .

LEUKEMIA RESEARCH, 2005, 29 (03) :263-271

[5] Cell targeting by a generic receptor-targeted polymer nanocontainer platform [J].

Broz, P ;

Benito, SM ;

Saw, C ;

Burger, P ;

Heider, H ;

Pfisterer, M ;

Marsch, S ;

Meier, W ;

Hunziker, P .

JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) :475-488

[6] From conventional to stealth liposomes: a new frontier in cancer chemotherapy [J].

Cattel, L ;

Ceruti, M ;

Dosio, F .

JOURNAL OF CHEMOTHERAPY, 2004, 16 :94-97

[7] Prodrug strategies in cancer therapy [J].

Denny, WA .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (7-8) :577-595

[8] Virus-assisted loading of polymer nanocontainer [J].

Graff, A ;

Sauer, M ;

Van Gelder, P ;

Meier, W .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5064-5068

[9] Encapsulation of therapeutic nucleoside hydrolase in functionalised nanocapsules [J].

Huysmans, G ;

Ranquin, A ;

Wyns, L ;

Steyaert, J ;

Van Gelder, P .

JOURNAL OF CONTROLLED RELEASE, 2005, 102 (01) :171-179

[10] Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy [J].

Kakinuma, H ;

Fujii, I ;

Nishi, Y .

JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 269 (1-2) :269-281